TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Short Versus Long IVF-treatment. A Prospective, Consecutive and Randomized Comparative Study
Brief Summary: Purpose: Comparing a GnRH agonist and an antagonist protocol for IVF/ICSI with regard to

1. frequency of ovarian hyperstimulation syndrome (OHSS) (1. outcome measure)
2. quality of life (2. outcome measure)
3. live birth rate (2. outcome measure)
4. gene expression profiles of granulosa and cumulus cells, and concentrations of estradiol and vascular endothelial growth factor in follicular fluid(not only compared between GnRH agonist and antagonist protocol, but also between patients with OHSS and no OHSS and patients becoming pregnant and not becoming pregnant (2. outcome measure), and
5. number of oocytes removed per treatment, number of embryo transfers per treatment and number of spontaneous abortions per treatment (these three parameters are tertiary outcome measures).

In addition to the above mentioned efficacy outcome measures the safety outcome measure "frequency of known side-effects" will be compared between the two protocols.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Patients receiving short protocol IVF/ICSI-treatment. | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Long protocol | Intervention Type: DRUG; Name: Patients receiving short protocol IVF/ICSI-treatment.; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Long protocol; Assigned to Arm(s): 2
B: Arm Label: 5.2 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 6.9 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 8.6 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 10.3 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 12.1 µg; Type: EXPERIMENTAL; Interventions: Drug: FE 999049 | Arm Label: 11 µg FbM (150 IU); Type: ACTIVE_COMPARATOR; Interventions: Drug: Gonal - F | Intervention Type: DRUG; Name: FE 999049; Assigned to Arm(s): 10.3 µg, 12.1 µg, 5.2 µg, 6.9 µg, 8.6 µg | Intervention Type: DRUG; Name: Gonal - F; Assigned to Arm(s): 11 µg FbM (150 IU)
C: Arm Label: AMH-group; Type: EXPERIMENTAL; Interventions: Other: AMH-analysis | Arm Label: Non-AMH-group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: AMH-analysis; Assigned to Arm(s): AMH-group
D: Arm Label: 450 IU daily dose of gonadotrophin; Type: ACTIVE_COMPARATOR; Interventions: Drug: menotropins for injection, Drug: urofollitropin for injection | Arm Label: 600 IU daily dose of gonadotrophin; Type: EXPERIMENTAL; Interventions: Drug: menotropins for injection, Drug: urofollitropin for injection | Intervention Type: DRUG; Name: menotropins for injection; Assigned to Arm(s): 450 IU daily dose of gonadotrophin, 600 IU daily dose of gonadotrophin | Intervention Type: DRUG; Name: urofollitropin for injection; Assigned to Arm(s): 450 IU daily dose of gonadotrophin, 600 IU daily dose of gonadotrophin

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Short Versus Long IVF-treatment. A Prospective, Consecutive and Randomized Comparative Study
Brief Summary: Purpose: Comparing a GnRH agonist and an antagonist protocol for IVF/ICSI with regard to

1. frequency of ovarian hyperstimulation syndrome (OHSS) (1. outcome measure)
2. quality of life (2. outcome measure)
3. live birth rate (2. outcome measure)
4. gene expression profiles of granulosa and cumulus cells, and concentrations of estradiol and vascular endothelial growth factor in follicular fluid(not only compared between GnRH agonist and antagonist protocol, but also between patients with OHSS and no OHSS and patients becoming pregnant and not becoming pregnant (2. outcome measure), and
5. number of oocytes removed per treatment, number of embryo transfers per treatment and number of spontaneous abortions per treatment (these three parameters are tertiary outcome measures).

In addition to the above mentioned efficacy outcome measures the safety outcome measure "frequency of known side-effects" will be compared between the two protocols.


Options:
A: Arm Label: GnRH agonist; Type: EXPERIMENTAL; Interventions: Drug: Triptorelin | Arm Label: GnRH antagonist; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cetrorelix | Intervention Type: DRUG; Name: Triptorelin; Assigned to Arm(s): GnRH agonist | Intervention Type: DRUG; Name: Cetrorelix; Assigned to Arm(s): GnRH antagonist
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Patients receiving short protocol IVF/ICSI-treatment. | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Long protocol | Intervention Type: DRUG; Name: Patients receiving short protocol IVF/ICSI-treatment.; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Long protocol; Assigned to Arm(s): 2
C: Arm Label: Observational Cohort; Type: N/A; Interventions: Drug: ganirelix | Arm Label: Historical Controls; Type: N/A; Interventions: Drug: GnRH agonist | Intervention Type: DRUG; Name: ganirelix; Assigned to Arm(s): Observational Cohort | Intervention Type: DRUG; Name: GnRH agonist; Assigned to Arm(s): Historical Controls
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: ganirelix | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: triptorelin | Intervention Type: DRUG; Name: ganirelix; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: triptorelin; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Short Versus Long IVF-treatment. A Prospective, Consecutive and Randomized Comparative Study
Brief Summary: Purpose: Comparing a GnRH agonist and an antagonist protocol for IVF/ICSI with regard to

1. frequency of ovarian hyperstimulation syndrome (OHSS) (1. outcome measure)
2. quality of life (2. outcome measure)
3. live birth rate (2. outcome measure)
4. gene expression profiles of granulosa and cumulus cells, and concentrations of estradiol and vascular endothelial growth factor in follicular fluid(not only compared between GnRH agonist and antagonist protocol, but also between patients with OHSS and no OHSS and patients becoming pregnant and not becoming pregnant (2. outcome measure), and
5. number of oocytes removed per treatment, number of embryo transfers per treatment and number of spontaneous abortions per treatment (these three parameters are tertiary outcome measures).

In addition to the above mentioned efficacy outcome measures the safety outcome measure "frequency of known side-effects" will be compared between the two protocols.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Patients receiving short protocol IVF/ICSI-treatment. | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Long protocol | Intervention Type: DRUG; Name: Patients receiving short protocol IVF/ICSI-treatment.; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Long protocol; Assigned to Arm(s): 2
B: Arm Label: Follicular flushing; Type: ACTIVE_COMPARATOR; Interventions: Other: Aspiration without flushing follicles with culture media, Other: Follicular Flushing | Intervention Type: OTHER; Name: Aspiration without flushing follicles with culture media; Assigned to Arm(s): Follicular flushing | Intervention Type: OTHER; Name: Follicular Flushing; Assigned to Arm(s): Follicular flushing
C: Arm Label: follicular flushing group; Type: EXPERIMENTAL; Interventions: Other: follicular flushing | Arm Label: aspiration group; Type: ACTIVE_COMPARATOR; Interventions: Other: no follicular flushing | Intervention Type: OTHER; Name: follicular flushing; Assigned to Arm(s): follicular flushing group | Intervention Type: OTHER; Name: no follicular flushing; Assigned to Arm(s): aspiration group
D: Arm Label: SL1(Cook® Single Lumen); Type: ACTIVE_COMPARATOR; Interventions: Device: Oocyte retrieval with only aspiration system "SL1(Cook® Single Lumen)" | Arm Label: DL1 (Cook® EchoTip® Double Lumen); Type: ACTIVE_COMPARATOR; Interventions: Device: Oocyte retrieval with aspiration and flushing system "DL1 (Cook® EchoTip® Double Lumen)" | Intervention Type: DEVICE; Name: Oocyte retrieval with only aspiration system "SL1(Cook® Single Lumen)"; Assigned to Arm(s): SL1(Cook® Single Lumen) | Intervention Type: DEVICE; Name: Oocyte retrieval with aspiration and flushing system "DL1 (Cook® EchoTip® Double Lumen)"; Assigned to Arm(s): DL1 (Cook® EchoTip® Double Lumen)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Use of Low Molecular Weight Heparin in Hemodiafiltration
Brief Summary: Low molecular weight heparin (LMWH) is injected in the dialysis circuit at the start of the session. In the present study we compare 3 different methods of injection of LMWH: parameters of dialysis efficiency and clotting are measured. The study lasts 3 sessions for each patient.


Options:
A: Arm Label: AD- acetic acid dialysate; Type: ACTIVE_COMPARATOR; Interventions: Other: acetic-acid based dialysate (AD) | Arm Label: CD - citrasate dialysate; Type: EXPERIMENTAL; Interventions: Other: citrate dialysate (CD) | Intervention Type: OTHER; Name: citrate dialysate (CD); Assigned to Arm(s): CD - citrasate dialysate | Intervention Type: OTHER; Name: acetic-acid based dialysate (AD); Assigned to Arm(s): AD- acetic acid dialysate
B: Intervention Type: PROCEDURE; Name: anticoagulation procedure; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: At start of the session, at the inlet line | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: 5 minutes after the start of the session, at the inlet line | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Procedure: At the start of the session, at the outlet line | Intervention Type: PROCEDURE; Name: At start of the session, at the inlet line; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: 5 minutes after the start of the session, at the inlet line; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: At the start of the session, at the outlet line; Assigned to Arm(s): 3
D: Arm Label: ATA plus citrate; Type: EXPERIMENTAL; Interventions: Device: dialyzer, Combination Product: hemodialysis with citrate-containing dialysate | Arm Label: ATA plus predilution hemodiafiltration; Type: ACTIVE_COMPARATOR; Interventions: Device: dialyzer, Other: predilution hemodiafiltration | Intervention Type: DEVICE; Name: dialyzer; Assigned to Arm(s): ATA plus citrate, ATA plus predilution hemodiafiltration | Intervention Type: COMBINATION_PRODUCT; Name: hemodialysis with citrate-containing dialysate; Assigned to Arm(s): ATA plus citrate | Intervention Type: OTHER; Name: predilution hemodiafiltration; Assigned to Arm(s): ATA plus predilution hemodiafiltration

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Control Trial of Surgical Masks vs N95 Respirators to Prevent Influenza in Health Care Workers
Brief Summary: The goal of this study is to compare the efficacy of the surgical mask to the N95 respirator in protecting nurses from influenza in the hospital setting. The investigators propose a non-inferiority randomized controlled trial whereby nurses are randomized to either a surgical mask or an N95 respirator when caring for patients with febrile respiratory illness during the influenza season. The hypothesis is that the surgical mask offers similar protection against influenza to that of the N95. The specific objective of the study is to assess whether the rates of influenza (laboratory-confirmed by PCR and HAI assay), as well as secondary outcomes (influenza-like illness, work-related absenteeism, physician visits for respiratory illness, and lower respiratory infection), are similar among nurses using a surgical mask compared to those using an N95 respirator.


Options:
A: Arm Label: Hand sanitizer group; Type: EXPERIMENTAL; Interventions: Other: hand sanitizer | Arm Label: Liquid soap group; Type: EXPERIMENTAL; Interventions: Other: liquid soap | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: hand sanitizer; Assigned to Arm(s): Hand sanitizer group | Intervention Type: OTHER; Name: liquid soap; Assigned to Arm(s): Liquid soap group
B: Arm Label: Facemask and hand hygiene; Type: EXPERIMENTAL; Interventions: Behavioral: Ear Loop Procedure Mask, Behavioral: 62% Ethyl Alcohol Hand Sanitizer | Arm Label: Facemask only; Type: EXPERIMENTAL; Interventions: Behavioral: Ear Loop Procedure Mask | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Ear Loop Procedure Mask; Assigned to Arm(s): Facemask and hand hygiene, Facemask only | Intervention Type: BEHAVIORAL; Name: 62% Ethyl Alcohol Hand Sanitizer; Assigned to Arm(s): Facemask and hand hygiene
C: Arm Label: Green tea; Type: EXPERIMENTAL; Interventions: Dietary Supplement: green tea | Arm Label: water; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: green tea | Intervention Type: DIETARY_SUPPLEMENT; Name: green tea; Assigned to Arm(s): Green tea, water
D: Arm Label: 1. Surgical; Type: ACTIVE_COMPARATOR; Interventions: Device: Surgical mask | Arm Label: 2. N95 Respirator; Type: ACTIVE_COMPARATOR; Interventions: Device: N95 mask | Intervention Type: DEVICE; Name: Surgical mask; Assigned to Arm(s): 1. Surgical | Intervention Type: DEVICE; Name: N95 mask; Assigned to Arm(s): 2. N95 Respirator

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Control Trial of Surgical Masks vs N95 Respirators to Prevent Influenza in Health Care Workers
Brief Summary: The goal of this study is to compare the efficacy of the surgical mask to the N95 respirator in protecting nurses from influenza in the hospital setting. The investigators propose a non-inferiority randomized controlled trial whereby nurses are randomized to either a surgical mask or an N95 respirator when caring for patients with febrile respiratory illness during the influenza season. The hypothesis is that the surgical mask offers similar protection against influenza to that of the N95. The specific objective of the study is to assess whether the rates of influenza (laboratory-confirmed by PCR and HAI assay), as well as secondary outcomes (influenza-like illness, work-related absenteeism, physician visits for respiratory illness, and lower respiratory infection), are similar among nurses using a surgical mask compared to those using an N95 respirator.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Alcohol-based hand sanitizer & quaternary ammonium wipes | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Alcohol-based hand sanitizer & quaternary ammonium wipes; Assigned to Arm(s): 1
B: Arm Label: 1. Surgical; Type: ACTIVE_COMPARATOR; Interventions: Device: Surgical mask | Arm Label: 2. N95 Respirator; Type: ACTIVE_COMPARATOR; Interventions: Device: N95 mask | Intervention Type: DEVICE; Name: Surgical mask; Assigned to Arm(s): 1. Surgical | Intervention Type: DEVICE; Name: N95 mask; Assigned to Arm(s): 2. N95 Respirator
C: Arm Label: Hand washing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Hand washing | Arm Label: Disinfectant rubbing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Disinfectant rubbing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Hand washing; Assigned to Arm(s): Hand washing | Intervention Type: BEHAVIORAL; Name: Disinfectant rubbing; Assigned to Arm(s): Disinfectant rubbing
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: health education | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: hand hygiene | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: hand hygiene, Device: face masks | Intervention Type: BEHAVIORAL; Name: hand hygiene; Assigned to Arm(s): 2, 3 | Intervention Type: OTHER; Name: health education; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: face masks; Assigned to Arm(s): 3

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Control Trial of Surgical Masks vs N95 Respirators to Prevent Influenza in Health Care Workers
Brief Summary: The goal of this study is to compare the efficacy of the surgical mask to the N95 respirator in protecting nurses from influenza in the hospital setting. The investigators propose a non-inferiority randomized controlled trial whereby nurses are randomized to either a surgical mask or an N95 respirator when caring for patients with febrile respiratory illness during the influenza season. The hypothesis is that the surgical mask offers similar protection against influenza to that of the N95. The specific objective of the study is to assess whether the rates of influenza (laboratory-confirmed by PCR and HAI assay), as well as secondary outcomes (influenza-like illness, work-related absenteeism, physician visits for respiratory illness, and lower respiratory infection), are similar among nurses using a surgical mask compared to those using an N95 respirator.


Options:
A: Arm Label: 1; Type: OTHER; Interventions: Other: Control | Arm Label: 2; Type: OTHER; Interventions: Device: Masks | Arm Label: 3; Type: OTHER; Interventions: Device: Masks & hand hygiene | Intervention Type: DEVICE; Name: Masks; Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: Masks & hand hygiene; Assigned to Arm(s): 3 | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): 1
B: Arm Label: 1. Surgical; Type: ACTIVE_COMPARATOR; Interventions: Device: Surgical mask | Arm Label: 2. N95 Respirator; Type: ACTIVE_COMPARATOR; Interventions: Device: N95 mask | Intervention Type: DEVICE; Name: Surgical mask; Assigned to Arm(s): 1. Surgical | Intervention Type: DEVICE; Name: N95 mask; Assigned to Arm(s): 2. N95 Respirator
C: Arm Label: Medical Mask; Type: EXPERIMENTAL; Interventions: Device: Medical Mask | Arm Label: N95 respirator; Type: ACTIVE_COMPARATOR; Interventions: Device: N95 respirator | Intervention Type: DEVICE; Name: Medical Mask; Assigned to Arm(s): Medical Mask | Intervention Type: DEVICE; Name: N95 respirator; Assigned to Arm(s): N95 respirator
D: Arm Label: Chlorhexidine; Type: ACTIVE_COMPARATOR; Interventions: Other: Oral care with 0,12% Chlorhexidine | Arm Label: Placebo Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Oral care with 0,12% Chlorhexidine; Assigned to Arm(s): Chlorhexidine

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Feeding Young Children Study (FYCS)- a Randomized Control Trial of a Bottle Weaning Intervention Aimed at Reducing the Risk of Overweight in Low Income Multi-ethnic Toddlers.
Brief Summary: This Integrated Project (Research + Extension) aims to reduce the risk of early childhood overweight through changing bottle-feeding behavior. Excess bottles of whole milk and sweet beverages beyond the advised weaning age of 12 months, "inappropriate bottle-feeding," has been linked to overweight. Our pilot of this intervention reduced bottle use.

COMPONENTS OF THE 'FEEDING YOUNG CHILDREN STUDY' (FYCS):

1. Randomized Controlled Trial (RCT)- of a bottle-weaning intervention in low-income multi-ethnic toddlers, will enroll n=464 12 month olds using \>2 bottles/day from two WIC sites. Bottle use, anthropometrics, dietary intake, and nutrient density outcomes will be assessed at Baseline, and 4 times over a 12 month follow-up.
2. Observational Study- nested within the RCT, will describe dietary intake and nutrient density data (24 hour recalls) for this period of feeding transitions. FYCS fills a gap in knowledge about this population's dietary habits, and their relationship to bottle use.
3. Extension- our Marketing Department will produce: a 5-8 minute 'infomercial' and nutritionist and client guides (freely downloadable) at WIC, maternal/child health, and pediatric websites, and; a public TV segment. We will disseminate findings through a) the National WIC Association, b) nutrition \& pediatric journals, and; c) lay print, media, and websites with assistance from our Public Relations Department.


Options:
A: Arm Label: Walking/Running Program; Type: EXPERIMENTAL; Interventions: Behavioral: Walking/Running program | Arm Label: Classroom activity break program; Type: EXPERIMENTAL; Interventions: Behavioral: Classroom physical activity break program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Walking/Running program; Assigned to Arm(s): Walking/Running Program | Intervention Type: BEHAVIORAL; Name: Classroom physical activity break program; Assigned to Arm(s): Classroom activity break program
B: Arm Label: HOP'N After-School Program; Type: EXPERIMENTAL; Interventions: Behavioral: HOP'N After-school Program | Intervention Type: BEHAVIORAL; Name: HOP'N After-school Program; Assigned to Arm(s): HOP'N After-School Program
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Bottle Weaning Intervention | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Bottle Weaning Intervention; Assigned to Arm(s): 1
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: physical activity; Assigned to Arm(s): Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Injection Treatment of Slow-Release Corticosteroid to the Sacrospinous Ligament Insertions on Women With Long-Lasting Low Back Pain Starting in Pregnancy.
Brief Summary: To evaluate the pain relief effect of locally injected corticosteroid treatment in women with long-lasting low back pain beginning in pregnancy. We hypothesize that the insertion of the sacrospinous ligament on the ischial spine would be a source of pain and therefore be a target for therapy.

Primary outcome measure is reported pain intensity on visual analogue scale and secondary outcome measures number of pain-drawing locations, pain-provoking test results and tests of function.


Options:
A: Arm Label: postural orientations; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: hatha yoga | Arm Label: hatha yoga exercises; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: hatha yoga | Intervention Type: BEHAVIORAL; Name: hatha yoga; Assigned to Arm(s): hatha yoga exercises, postural orientations
B: Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Arm Label: Spinal Manipulation; Type: EXPERIMENTAL; Interventions: Procedure: Spinal Manipulation | Arm Label: Neuroemotional technique (NET); Type: EXPERIMENTAL; Interventions: Procedure: Neuroemotional Technique (NET) | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise | Intervention Type: PROCEDURE; Name: Spinal Manipulation; Assigned to Arm(s): Spinal Manipulation | Intervention Type: PROCEDURE; Name: Neuroemotional Technique (NET); Assigned to Arm(s): Neuroemotional technique (NET)
C: Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline solution | Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Triamcinolone | Intervention Type: DRUG; Name: Triamcinolone; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Saline solution; Assigned to Arm(s): B
D: Arm Label: Exercice; Type: OTHER; Interventions: Behavioral: preparation of the delivery | Arm Label: non-exercice; Type: OTHER; Interventions: Behavioral: preparation of the delivery | Intervention Type: BEHAVIORAL; Name: preparation of the delivery; Assigned to Arm(s): Exercice, non-exercice

Answer: C